Roche, Alere Win NICE Pre-Eclampsia Nod But Perkin Elmer, Thermo Fisher Lose Out
This article was originally published in Clinica
Executive Summary
The UK’s National Institute for Health and Care Excellence has recommended that the National Health Service use two blood tests – Roche Diagnostics’ Elecsys immunoassay sFlt-1/PlGF ratio and Alere’s Triage PlGF – to help rule out pre-eclampsia, a potentially life-threatening complication that occurs during late pregnancy.